Physician profile
Benjamin Mulkey
NPI 1124522115
$35,956.81
in general payments reported to CMS, 2019-2025
20 companies · $23K in 2025
The $23K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $308 · 2023: $832 · 2024: $12K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $10K · Grant: $10K · Education: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,311.31 |
| Food and Beverage | $10,458.92 |
| Grant | $10,000.00 |
| Education | $699.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,930.80 | 2023-2025 | Micra, Onyx Frontier, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $8,916.47 | 2023-2025 | Ensite, Tacticath, Assurity |
| Biotronik INC. | $5,841.72 | 2024-2025 | |
| Biosense Webster, INC. | $4,996.11 | 2025 | Carto 3 |
| Boston Scientific Corporation | $4,376.18 | 2024-2025 | Versacross Access Solution, Accolade Sr, Watchman Flx |
| Medical Device Business Services, INC. | $486.08 | 2024 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $394.15 | 2021-2024 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $175.21 | 2024 | Arcalyst |
| Abiomed | $160.54 | 2024 | Impella |
| Cardiovascular Systems INC. | $126.45 | 2021 | |
| Pfizer INC. | $125.99 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.10 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $73.89 | 2022 | |
| Teleflex LLC | $66.48 | 2022 | |
| Stryker Corporation | $44.41 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $43.54 | 2024 | (Cm9) Amb Mon & Diag Und |
| Recor Medical INC | $25.48 | 2025 | Paradise Ultrasound Renal Denervation System |
| Janssen Pharmaceuticals, INC | $21.64 | 2024 | Xarelto |
| Inari Medical, INC. | $20.82 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bridgebio Pharma, INC. | $18.75 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mulkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.